產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
![HUV-EC-C [HUVEC]細(xì)胞專用培養(yǎng)基](/Public/upfile/pic/product/Complete-Medium-for-Cell-Lines-01.jpg)
![HUV-EC-C [HUVEC]細(xì)胞專用培養(yǎng)基](/Public/upfile/pic/product/Complete-Medium-for-Cell-Lines-02.jpg)
![HUV-EC-C [HUVEC]細(xì)胞專用培養(yǎng)基](/Public/upfile/pic/product/Complete-Medium-for-Cell-Lines-03.jpg)
![HUV-EC-C [HUVEC]細(xì)胞專用培養(yǎng)基](/Public/upfile/pic/product/Complete-Medium-for-Cell-Lines-04.jpg)
HUV-EC-C [HUVEC]細(xì)胞專用培養(yǎng)基
貨號：CM-0122
價格：￥2680￥￥
- 125mL×4
產(chǎn)品概述
產(chǎn)品簡介
HUV-EC-C [HUVEC]細(xì)胞專用培養(yǎng)基由普諾賽技術(shù)團(tuán)隊精心優(yōu)化，經(jīng)過長期測試，本產(chǎn)品可保持HUV-EC-C [HUVEC]細(xì)胞最佳的生長狀態(tài)。本產(chǎn)品中已包含HUV-EC-C [HUVEC]細(xì)胞生長所需的各種成分，無需添加任何成分，可直接用于HUV-EC-C [HUVEC]細(xì)胞的體外培養(yǎng)。本產(chǎn)品僅供進(jìn)一步科研使用，不得用于診斷、治療、臨床、家庭及其它用途。
產(chǎn)品說明
| 產(chǎn)品形態(tài) | 液體 |
| 產(chǎn)品濃度 | 1× |
| 產(chǎn)品規(guī)格 | 125mL×4 |
| 培養(yǎng)基成分 | Complete culture medium for HUV-EC-C |
| 細(xì)菌檢測 | 陰性 |
| 真菌檢測 | 陰性 |
| 支原體檢測 | 陰性 |
| 細(xì)胞生長實驗 | 細(xì)胞生長良好，形態(tài)正常 |
| 內(nèi)毒素含量(EU/mL) | ≤3 |
| 儲存條件 | 2~8℃，避光儲存 |
| 運輸條件 | 冰袋冷藏運輸 |
| 有效期 | 3個月 |
注意事項
1、使用產(chǎn)品時應(yīng)注意無菌操作，避免污染。 2、本產(chǎn)品含有血清和雙抗，如無特別需要不用額外再添加血清和雙抗，可以直接使用。 3、為保持本產(chǎn)品的最佳使用效果，不宜將其長時間放置于室溫或較高的溫度環(huán)境中。 4、所有產(chǎn)品請于保質(zhì)期內(nèi)使用，超出保質(zhì)期，必須放棄使用。 5、本產(chǎn)品只供進(jìn)一步科研使用，不可應(yīng)用于臨床等其他方面。
參考文獻(xiàn)
-
Ultra-high antioxidant, anti-apoptosis and pro-angiogenesis effect of Mo2C nanosheets for treatment of diabetic wounds(2024/02/15)
作者：Yaping Ren, Xiaolin Zhou, Xuejiao Gao
期刊：Nano Today
DOI：10.1016/j.nantod.2024.102202
影響因子 ：17.400
引用產(chǎn)品：CM-0122
-
Blow-Spun Si3N4-Incorporated Nanofibrous Dressing with Antibacterial, Anti-Inflammatory, and Angiogenic Activities for Chronic Wound Treatment(2024/02/13)
作者：Pengchao Ma, Chunyi Yang, Chengli Li
期刊：Advanced Fiber Materials
DOI：10.1007/s42765-023-00361-w
影響因子 ：16.100
引用產(chǎn)品：CM-0122
-
A novel UV-curable extravascular stent to prevent restenosis of venous grafts(2021/08/30)
作者：Chun Dai, Tianshu Chu, Xiang Li
期刊：Composites Part B-Engineering
DOI：10.1016/j.compositesb.2021.109260
影響因子 ：13.100
引用產(chǎn)品：CM-0122
-
Silicon-Phosphorus-Nanosheets-Integrated 3D-Printable Hydrogel as a Bioactive and Biodegradable Scaffold for Vascularized Bone Regeneration(2021/12/16)
作者：Chao Xu, Yukai Chang, Yan Xu
期刊：Advanced Healthcare Materials
影響因子 ：11.092
引用產(chǎn)品：CM-0122
-
Dual-Cues Laden Scaffold Facilitates Neurovascular Regeneration and Motor Functional Recovery After Complete Spinal Cord Injury(2021/3/19)
作者：Dingyang Liu, He Shen, Yeyu Shen
期刊：Advanced Healthcare Materials
影響因子 ：10.000
引用產(chǎn)品：CM-0122
-
Copper Ion-Modified Germanium Phosphorus Nanosheets Integrated with an Electroactive and Biodegradable Hydrogel for Neuro-Vascularized Bone Regeneration(2023/07/08)
作者：Yan Xu, Chao Xu, Kun Yang
期刊：Advanced Healthcare Materials
影響因子 ：10.000
引用產(chǎn)品：CM-0122
-
Cell-Penetrating Peptide-Functionalized Persistent Luminescence Nanoparticles for Tracking J774A.1 Macrophages Homing to Inflamed Tissues(2019/05/13)
作者：Lijian Chen, Xu Zhao, Xiuping Yan
期刊：ACS Applied Materials & Interfaces
影響因子 ：9.500
-
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis(2022/10/22)
作者：Huiping Ma, Shuyun Qu, Yao Zhai
期刊：CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI：10.1186/s11658-022-00364-2
影響因子 ：8.300
-
ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy(2023/03/22)
作者：Jingyi Zhou, Kangkang Li, Xinlong Zang
期刊：International Journal of Nanomedicine
影響因子 ：8.000
引用產(chǎn)品：CM-0122
-
Sapylin (OK-432) alters inflammation and angiogenesis in vivo and vitro(2019/03/04)
作者：Deguang Kong, Dan Zhang, Qiuxia Cui
期刊：Biomedicine & Pharmacotherapy
DOI：10.1016/j.biopha.2019.108706
影響因子 ：7.500
-
Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Suppresses macrophage capping protein beyond STING activation(2024/04/01)
作者：Zhiyong Xiao, Xia Cui, Feng Liu
期刊：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
DOI：10.1016/j.bbadis.2024.167149
影響因子 ：6.200
引用產(chǎn)品：CM-0122
-
A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma(2022/03/31)
作者：Jing Xiang, Lin Ma, Zheng Gu
期刊：Cells
影響因子 ：6.000
引用產(chǎn)品：CM-0122
-
A strategy for oral delivery of FGF21 for mitigating inflammation and multi-organ damage in sepsis(2024/04/12)
作者：Xinze Li, Dedong Yu, Xuanhe Chen
期刊：INTERNATIONAL JOURNAL OF PHARMACEUTICS
DOI：10.1016/j.ijpharm.2024.124115
影響因子 ：5.800
引用產(chǎn)品：CM-0122
-
DHX9 Strengthens Atherosclerosis Progression By Promoting Inflammation in Macrophages(2023/06/16)
作者：Huangfu Ning, Hongchuang Ma, Mengyun Tian
期刊：INFLAMMATION
DOI：10.1007/s10753-023-01836-z
影響因子 ：5.100
引用產(chǎn)品：CM-0122
-
Functionalized Magnesium Phosphate Cement Induces In Situ Vascularized Bone Regeneration via Surface Lyophilization of Chondroitin Sulfate(2023/12/28)
作者：Changtian Gong, Jian Yang, Xiping Zhang
期刊：Biomedicines
DOI：10.3390/biomedicines12010074
影響因子 ：4.700
引用產(chǎn)品：CM-0122
-
Comparison of Gelatin/Polylysine- and Silk Fibroin/SDF-1α-Coated Mesenchymal Stem cell-Seeded Intracranial Stents(2022/12/21)
作者：Qichen Peng, Ruimin Guo, Yangyang Zhou
期刊：MACROMOLECULAR BIOSCIENCE
影響因子 ：4.600
-
Inhibition of Matrix Metalloproteinase-8 Protects Against Sepsis Serum Mediated Leukocyte Adhesion(2022/01/25)
作者：Xiao Fang, Shufang Duan, Zhiyuan Hu
期刊：Frontiers in Medicine
影響因子 ：3.900
引用產(chǎn)品：CM-0122
-
Long noncoding RNA H19 synergizes with STAT1 to regulate SNX10 in rheumatoid arthritis(2022/11/29)
作者：Yue Sun, Yun Guo, Lihua Chang, Jing Zhang
期刊：MOLECULAR IMMUNOLOGY
DOI：10.1016/j.molimm.2022.11.018
影響因子 ：3.600
-
Circ_0026218 ameliorates oxidized low-density lipoprotein-induced vascular endothelial cell dysfunction by regulating miR-188-3p/TLR4/NF-κB pathway(2022/12/31)
作者：Jing Liu, Xiangyang Zhang, Zhaoxia Yu
期刊：CARDIOVASCULAR DRUGS AND THERAPY
DOI：10.1007/s10557-022-07416-x
影響因子 ：3.400
引用產(chǎn)品：CM-0122
-
Sympathetic activation leads to Schlemms canal expansion via increasing vasoactive intestinal polypeptide secretion from trabecular meshwork(2022/08/30)
作者：Dingwen Xu, Feipeng Wu, Yixian Yu
期刊：EXPERIMENTAL EYE RESEARCH
DOI：10.1016/j.exer.2022.109235
影響因子 ：3.400
引用產(chǎn)品：CM-0122
-
Targeting USP11 may alleviate radiation-induced pulmonary fibrosis by regulating endothelium tight junction(2021/11/11)
作者：Yiting Tang, Qian Yuan, Congzhao Zhao
期刊：International Journal of Radiation Biology
DOI：10.1080/09553002.2022.1998711
影響因子 ：3.352
-
CircDiaph3 influences PASMC apoptosis by regulating PI3K/AKT/mTOR pathway through IGF1R(2023/09/11)
作者：Ge Liu, Shengqiang Zhang, Shaofeng Yang
期刊：3 Biotech
DOI：10.1007/s13205-023-03739-0
影響因子 ：2.800
引用產(chǎn)品：CM-0122
-
Long non?coding RNA PEG13 regulates endothelial cell senescence through the microRNA?195/IRS1 axis(2023/11/03)
作者：Qin Huang, Haiwen Zhou, Songping Yu
期刊：Experimental and Therapeutic Medicine
影響因子 ：2.700
引用產(chǎn)品：CM-0122
-
Tectorigenin protect HUVECs from H2O2-induced oxidative stress injury by regulating PI3K/Akt pathway(2020/12/29)
作者：Xiao Chen, Weijia Zhang, Lirui Sun
期刊：Tissue & Cell
DOI：10.1016/j.tice.2020.101475
影響因子 ：2.600
-
Procyanidin B2 alleviates oxidized low-density lipoprotein-induced cell injury, inflammation, monocyte chemotaxis, and oxidative stress by inhibiting the nuclear factor kappa-B pathway in human umbilical vein endothelial cells(2024/04/29)
作者：Limei Yuan, Lihua Fan, Zhiqiang Zhang
期刊：BMC Cardiovascular Disorders
DOI：10.1186/s12872-024-03858-3
影響因子 ：2.100
引用產(chǎn)品：CM-0122
-
Hsa_circ_0004831 downregulation is partially responsible for atorvastatinalleviated human umbilical vein endothelial cell injuries induced by ox-LDL through targeting the miR-182-5p/CXCL12 axis(2021/5/1)
作者：Gang Su, Guangli Sun, Jian Lv
期刊：BMC Cardiovascular Disorders
DOI：10.1186/s12872-021-01998-4
影響因子 ：2.100
引用產(chǎn)品：CM-0122
-
Circular RNA circ_0029589 promotes ox-LDL-induced endothelial cell injury through regulating RAB22A by serving as a sponge of miR-1197(2023/01/01)
作者：Dequan He, Zhiliang Li, Youquan Chen
期刊：CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
影響因子 ：2.100
引用產(chǎn)品：CM-0122
-
High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression(2024/05/09)
作者：Aohang Li, Jingxuan Wu
期刊：Open Medicine
影響因子 ：2.100
引用產(chǎn)品：CM-0122
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識別碼示意圖
